A Phase III Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled, Multiple Dose, Clinical Trial to Study the Safety and Efficacy of MK-0663/Etoricoxib and Ibuprofen in the Treatment of Postorthopedic Knee Replacement Surgery Pain (MERCK CO., INC.USA)